V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10400222 | 10040963 | 1.86 | 85.1 | Curative (C) | 2019-02-19 | 2019-03-04 | Sunitinib | null | N | BUSULFAN | 101630281 |
| 10400226 | 10040964 | 1.6 | 0 | 03 | 2021-12-18 | 2021-12-18 | FLUOROURACIL | null | null | FLUOROURACIL | 101185118 |
| 10400302 | 10040965 | 1.6 | 70.8 | Neo-adjuvant (N) | 2017-01-28 | 2019-08-19 | CHOP R | 02 | null | CHOP R | 100044789 |
| 10400388 | 10040966 | 1.72 | 74.7 | 02 | 2019-12-26 | 2019-12-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100851173 |
| 10400432 | 10040967 | 1.81 | 74.8 | 02 | 2020-02-19 | 2020-02-19 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101771481 |
| 10400596 | 10040969 | 1.67 | 57.8 | Adjuvant (A) | 2010-05-15 | 2018-07-02 | Acalabrutinib | null | null | ACALABRUTINIB | 100590332 |
| 10400603 | 10040970 | 1.46 | 68 | null | null | 2019-06-17 | CHOP R - 21 days | 02 | null | CHOP R | 100590322 |
| 10400699 | 10040971 | 1.77 | 63.2 | Palliative (P) | 2017-12-01 | 2017-12-16 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100876201 |
| 10400781 | 10040972 | 1.85 | 62.8 | 03 | 2018-07-07 | 2018-07-20 | CHOP R - 21 days | N | N | CHOP R | 100426029 |
| 10400869 | 10040973 | null | 94.3 | 03 | 2019-02-04 | 2019-02-19 | DARATUMUMAB | 02 | N | CAPECITABINE + CISPLATIN | 100938764 |
| 10400896 | 10040974 | 1.56 | 104 | Neo-adjuvant (N) | 2019-01-06 | 2019-01-20 | Avelumab | 02 | N | AVELUMAB | 101530882 |
| 10401200 | 10040976 | 1.65 | 137 | 03 | 2018-12-28 | 2019-01-03 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100093510 |
| 10401235 | 10040977 | 1.65 | 120 | null | 2021-05-21 | 2021-05-23 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100972739 |
| 10401412 | 10040978 | 1.81 | 70.5 | Palliative (P) | 2018-11-08 | 2018-12-04 | CISPLATIN + FLUOROURACIL | 02 | N | VENETOCLAX | 100628000 |
| 10401421 | 10040979 | 1.69 | 0 | Palliative (P) | 2019-04-20 | 2019-05-04 | null | N | N | DABRAFENIB + TRAMETINIB | 101610417 |
| 10401470 | 10040980 | 1.59 | 65.6 | Palliative (P) | 2015-04-18 | 2015-05-02 | Venetoclax | 02 | N | CISPLATIN + VINORELBINE | 100371009 |
| 10401471 | 10040981 | null | 0 | null | 2022-04-07 | 2022-04-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101132985 |
| 10401485 | 10040982 | 1.57 | 59.7 | null | 2017-11-29 | 2017-12-13 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 100885464 |
| 10401509 | 10040983 | 1.7 | 93.8 | Curative (C) | 2020-01-24 | 2020-02-02 | CYTARABINE | 02 | null | BCG | 100367637 |
| 10401630 | 10040984 | 1.82 | 64 | Palliative (P) | 2021-08-27 | 2021-09-03 | Acalabrutinib | N | N | ACALABRUTINIB | 100554886 |
| 10401718 | 10040986 | 1.76 | 83.2 | Palliative (P) | 2019-07-30 | 2019-08-25 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100444905 |
| 10401866 | 10040989 | null | 0 | 02 | 2018-11-28 | 2018-11-30 | DABRAFENIB + TRAMETINIB | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100582020 |
| 10401999 | 10040991 | 1.65 | 85.1 | null | 2020-02-06 | 2020-02-08 | DARATUMUMAB | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100079227 |
| 10402022 | 10040992 | 1.84 | 65.7 | Curative (C) | 2022-02-10 | 2022-02-18 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101781732 |
| 10402038 | 10040994 | 1.6 | 86 | Palliative (P) | 2016-07-16 | 2016-08-01 | Avelumab | 02 | N | AVELUMAB | 100264407 |
| 10402166 | 10040995 | null | 66.2 | Neo-adjuvant (N) | 2017-12-26 | 2018-01-28 | DABRAFENIB + TRAMETINIB | null | N | MITOMYCIN | 100589648 |
| 10402289 | 10040998 | null | 78.4 | Neo-adjuvant (N) | 2019-09-29 | 2019-10-02 | Avelumab | 02 | N | AVELUMAB | 101847509 |
| 10402355 | 10040999 | null | 0 | null | null | 2022-05-06 | DABRAFENIB + TRAMETINIB | 02 | null | CLADRIBINE | 100699286 |
| 10402372 | 10041000 | 1.7 | 82.5 | Palliative (P) | 2018-03-25 | 2018-04-21 | null | 02 | N | VENETOCLAX | 100512754 |
| 10402433 | 10041001 | 1.57 | 79.3 | Disease modification (D) | 2017-11-12 | 2017-11-21 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101657710 |
| 10402525 | 10041003 | 1.57 | 89.5 | null | 2020-02-03 | 2020-02-03 | FEC 60 or 75 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100846645 |
| 10402629 | 10041006 | 1.86 | 87 | null | 2021-07-31 | 2021-08-06 | Palbociclib | 02 | null | PALBOCICLIB | 100711099 |
| 10402664 | 10041007 | 1.72 | 65.05 | null | 2020-02-20 | 2020-02-20 | Sunitinib | N | null | CAPECITABINE + GEMCITABINE | 101381983 |
| 10402908 | 10041009 | 1.77 | 103.2 | 03 | 2017-12-05 | 2018-01-24 | CTD | N | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101040525 |
| 10403016 | 10041011 | 1.59 | 115.5 | null | null | 2022-03-22 | Avelumab | 2 | null | AVELUMAB | 100774534 |
| 10403035 | 10041012 | 0 | 87 | Curative (C) | 2019-03-10 | 2019-03-16 | Cyclophosphamide + Dex + Rituximab | 02 | null | CAPECITABINE + CISPLATIN | 101644426 |
| 10403107 | 10041013 | null | 94 | null | 2018-01-13 | 2018-01-13 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 101573942 |
| 10403126 | 10041014 | 1.65 | 70 | null | 2019-04-26 | 2019-05-07 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | DABRAFENIB + TRAMETINIB | 100034244 |
| 10403424 | 10041017 | 1.57 | 85.5 | 03 | 2017-08-31 | 2017-09-17 | CISPLATIN + FLUOROURACIL | 02 | N | CAPECITABINE + GEMCITABINE | 100991223 |
| 10403607 | 10041019 | 1.63 | 70 | null | 2021-11-02 | 2021-11-02 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100177845 |
| 10403721 | 10041021 | 1.77 | 69.5 | 03 | 2019-08-17 | 2019-08-25 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101230678 |
| 10404041 | 10041022 | 1.61 | 54.75 | Curative (C) | 2016-10-30 | 2016-10-30 | FEC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101275640 |
| 10404064 | 10041023 | 1.76 | 78 | null | 2017-09-19 | 2017-09-22 | Capecitabine + Cisplatin | null | null | CISPLATIN + FLUOROURACIL | 100169733 |
| 10404117 | 10041024 | 1.82 | 96.4 | Curative (C) | 2018-10-13 | 2018-10-13 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100045766 |
| 10404133 | 10041025 | 1.78 | null | Palliative (P) | 2018-02-18 | 2018-03-04 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101716845 |
| 10404140 | 10041026 | 1.68 | 67 | Not known (9) | 2016-09-04 | 2016-09-04 | BUSULFAN | 02 | null | TRIAL | 101849160 |
| 10404166 | 10041027 | 1.74 | 50.4 | Unknown (U) | 2018-07-31 | 2018-08-08 | Busulfan Oral | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100306446 |
| 10404173 | 10041028 | 1.54 | 76 | 03 | 2018-11-29 | 2018-12-21 | Palbociclib | 02 | N | PALBOCICLIB | 100877663 |
| 10404444 | 10041031 | 1.54 | 82.6 | null | 2020-04-25 | 2020-04-29 | Sunitinib | null | null | CVP R | 101732737 |
| 10404552 | 10041032 | 1.72 | 66.6 | Palliative (P) | 2016-07-03 | 2016-07-06 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100479681 |